价格

SARS-COV2 vaccine

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CHIMERIC PROTEIN PRODUCTION PROCESS, CHIMERIC PROTEIN, GENE, IMMUNOGENIC COMPOSITION AND USES
US 20250109421 A1申请人: UNIV MINAS GERAIS优先权: 2022
CN
EP
US
WO
4 件公开
IMMUNOGENS DERIVED FROM SARS-COV2 SPIKE PROTEIN
EP 4185322 A2申请人: AMGEN INC优先权: 2020
EP
US
WO
4 件公开
Nant COVID vaccine cross reactivity
US 11911459 B2申请人: IMMUNITYBIO INC优先权: 2021
CN
US
4 件公开
Tetanus vaccine platform for embedding COVID-19 vaccine
US 12194090 B2申请人: PRIME BIO INC优先权: 2022
US
2 件公开
VIRAL PREPARATIONS AND METHODS FOR TREATING AND MODULATING MITOCHONDRIAL EFFECTS OF CORONAVIRUS INFECTIONS.
US 20250327038 A1申请人: DAICH JULIAN优先权: 2025
US
2 件公开
PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)
EP 3892297 A1申请人: UNIV TUEBINGEN MEDIZINISCHE FAKULTAET优先权: 2020
EP
RECOMBINANT VACCINE AGAINST COVID-19 IN A VIRAL VECTOR
WO 2021229270 A1申请人: LABORATORIO AVI MEX S A DE C V优先权: 2020
WO
SARS-COV-2 VACCINES
- EP 3981425 A1
  申请人: R G C C HOLDINGS AG优先权: 2020
  EP
- US 11464851 B2
  申请人: R G C C HOLDINGS AG优先权: 2021
  US
VACCINE COMPOSITION FOR NOVEL CORONAVIRUS INFECTION
US 20250269009 A1申请人: RONGSEN BIOTECHNOLOGY BEIJING CO LTD优先权: 2020
US
Recombinant adeno-associated virus for preventing novel coronavirus infection in cats, construction method and application thereof
CN 112921007 A申请人: UNIV HUAZHONG AGRICULTURAL优先权: 2021
CN

药物

SARS-COV2 vaccine

专利

SARS-COV-2 VACCINES